Newspaper notice on Umang Vohra's appointment as Chairman and Group CEO

Cohance Lifesciences has published a newspaper notice in Business Standard and Navashakti under Section 201 of the Companies Act, 2013, about seeking Central Government approval for the appointment of Mr. Umang Vohra (Non-Resident, DIN 02296740) as Director and Chairman from 1 May 2026 and as Group CEO from 20 May 2026, both until 30 April 2031. The Board approved the appointments on 27 April 2026 and shareholders approved them via postal ballot on 13 June 2026. Central Government clearance is needed because Mr. Vohra is a Non-Resident.